Real-world effectiveness and tolerability of erenumab: A retrospective cohort study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world effectiveness and tolerability of erenumab: A retrospective cohort study
Authors
Keywords
-
Journal
CEPHALALGIA
Volume -, Issue -, Pages 033310242094672
Publisher
SAGE Publications
Online
2020-08-14
DOI
10.1177/0333102420946725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcitonin Gene-Related Peptide Monoclonal Antibody Treatments for Migraine
- (2019) Elizabeth Loder et al. JAMA Internal Medicine
- Analysis and reporting of adverse events in randomised controlled trials: a review
- (2019) Rachel Phillips et al. BMJ Open
- Erenumab: from scientific evidence to clinical practice—the first Italian real-life data
- (2019) Piero Barbanti et al. NEUROLOGICAL SCIENCES
- 074 Early australian experience with erenumab for chronic migraine
- (2019) Shuli Cheng et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
- (2018) Rebecca Burch et al. HEADACHE
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- New preventive treatments for migraine
- (2018) Rebecca Burch et al. BMJ-British Medical Journal
- New preventive treatments for migraine
- (2018) Rebecca Burch et al. BMJ-British Medical Journal
- Who Should Try New Antibody Treatments for Migraine?
- (2018) Elizabeth W. Loder et al. JAMA Neurology
- Adverse drug reactions
- (2018) Robin E Ferner et al. BMJ-British Medical Journal
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Why clinical trial outcomes fail to translate into benefits for patients
- (2017) Carl Heneghan et al. Trials
- Nocebo in headache
- (2016) Dimos D. Mitsikostas CURRENT OPINION IN NEUROLOGY
- Developing Therapeutic Antibodies for Neurodegenerative Disease
- (2013) Y. Joy Yu et al. Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started